Miren
Zuazo, PhD

Graduate in Biochemistry from the University of Navarra, Master’s Degree in Biomedicine from Pierre et Marie Curie University and Maastritch University, and Doctor in Oncoinmunology from Navarrabiomed and Public University of Navarre.

She developed her doctorate in the field of immunotherapy, focusing on the study of the molecular mechanisms underlying PD-L1/PD-1 blockade immunotherapy efficacy in cancer patients.

Currently, Miren is the Head of Customer Development Services in the Technological Innovation Department of VIVEbiotech.